rood blauwe elepsis logo Belegger.nl

Prosus in 2021

14.404 Posts
Pagina: «« 1 ... 507 508 509 510 511 ... 721 »» | Laatste | Omlaag ↓
  1. Piet Particulier 20 augustus 2021 16:03
    Dat dit aandeel zo laag staat is werkelijk lachwekkend. Net mijn posities vergroot in China tech, voor de geïnteresseerde naast Prosus:

    Alibaba, Netease, Baidu en Baozun.

    GEDULD!
  2. forum rang 8 Hopper58 20 augustus 2021 16:14
    Op finanzen.net:

    "JPMORGAN: Prosus "buy"
    Freitag, 20.08.21 14:35

    20210820 – NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat das Kursziel für Prosus nach Quartalszahlen der Beteiligung Tencent von 146 auf 134 Euro gesenkt, die Einstufung aber auf "Overweight" belassen. Dies schrieb Analyst Marcus Diebel in einer am Freitag vorliegenden Studie."
  3. forum rang 8 Pedro Ines Kuilen 20 augustus 2021 16:14
    quote:

    Julius Digibyte schreef op 20 augustus 2021 16:09:

    [...]

    Spreek voor jezelf ajb. Ik kots Cees niet uit, ik vind Cees geen waardeloze toevoeging en begrijp zijn frustratie. Lees zijn berichten niet als het je stoort.
    Exact! Cees is van toegevoegde waarde! En ik hou er niet van als men denkt voor mij te kunnen spreken! Heeft iemand enig idee waarom Prosus stijgt? Geld stroomt bij mij binnen!
  4. forum rang 4 Brimily 20 augustus 2021 17:39
    Ik vind het verbazend dat de bedrijven waarin Prosus een belang heeft vaak torenhoge koersen hebben terwijl ze (nog )geen winst maken.
    Het lijkt erop dat Prosus ook op deze waarderingen word afgestraft.
  5. xxxabc 20 augustus 2021 18:01
    Dit artikel verscheen vandaag in de South Cina Morning Post:

    South China Morning Post

    China’s crackdown on Big Tech is a short-term cost for long-term health: state media
    • Chinese state media outlets are trying to reassure rattled investors to maintain confidence in China’s internet companies
    • An ongoing regulatory clampdown has wiped out more than US$1.5 trillion from Chinese technology stocks

    Published: 1:39pm, 20 Aug, 2021

    China’s regulatory crackdown on the country’s technology sector, which has so farwiped out around US$1.5 trillion of value from tech stocks, is a short-term cost that must be paid to ensure the healthy long-term growth of the digital economy, argued an op-ed published by the state-run Economic Daily on Friday.
    An apparent attempt to soothe market fears, the piece was published as investors are beginning to reconsider the risks and returns of Chinese tech stocks as share prices continue to fall in both New York and Hong Kong in response to Beijing’s shifting policies.
    The regulatory crackdown aims to “maintain fair and reasonable market competition” and is “normal market governance” instead of targeting capital or specific industries and companies, the authors of the op-ed wrote.
    “It shows China’s determination to develop the digital economy. The rapid growth of China’s digital economy will not change, and China will continue to lead the global digital economy,” the commentary claimed.
    So far, Tencent Holdings has lost 45 per cent from its January peak this year. Alibaba Group Holding, the owner of the South China Morning Post, has lost nearly half of its value from a peak in October last year. Delivery services giant Meituan has lost over half its value and short video platform Kuaishou is trading at about a fifth of February peak when it debuted in Hong Kong. Regulators in Beijing have rushed to publish new regulations and initiate new campaigns to clip the wings of Big Tech. Since last year, regulators have revoked approval to go public, levied a huge antitrust fine, forced a company to relinquish exclusive deals, initiated a cybersecurity probe just days after an overseas listing, and signed the death warrantof an entire industry sector with just one single policy change.
    The “short-term fluctuations” in the stock market, however, are a necessary price to pay for “healthy development”, the Economic Daily op-ed argues.
    This is not the first time a Chinese state-run outlet has tried to ease investor concerns.
  6. forum rang 5 Betweter 20 augustus 2021 20:24
    quote:

    Brimily schreef op 20 augustus 2021 19:40:

    Kan ceesvanvliet geen eigen draadje openen?
    Dat doet hij toch al.
14.404 Posts
Pagina: «« 1 ... 507 508 509 510 511 ... 721 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.327
AB InBev 2 5.574
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 53.332
ABO-Group 1 27
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 11.731
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 197
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 18.058
Aedifica 3 997
Aegon 3.258 323.666
AFC Ajax 538 7.110
Affimed NV 2 6.356
ageas 5.844 109.951
Agfa-Gevaert 14 2.098
Ahold 3.540 74.441
Air France - KLM 1.025 35.710
AIRBUS 1 13
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.122
Alfen 17 27.302
Allfunds Group 4 1.614
Almunda Professionals (vh Novisource) 651 4.255
Alpha Pro Tech 1 17
Alphabet Inc. 1 443
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.487 114.835
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.845 246.154
AMG 972 136.075
AMS 3 73
Amsterdam Commodities 305 6.808
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 513
Antonov 22.632 153.605
Aperam 92 15.274
Apollo Alternative Assets 1 17
Apple 5 405
Arcadis 252 9.019
Arcelor Mittal 2.038 321.625
Archos 1 1
Arcona Property Fund 1 303
arGEN-X 17 10.724
Aroundtown SA 1 227
Arrowhead Research 5 9.790
Ascencio 1 35
ASIT biotech 2 697
ASMI 4.108 39.979
ASML 1.767 118.420
ASR Nederland 21 4.550
ATAI Life Sciences 1 7
Atenor Group 1 548
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 33 15.719
Axsome Therapeutics 1 177
Azelis Group 1 85
Azerion 7 3.609